2022
Utilization, cost, and prescription patterns of dupilumab among Medicare beneficiaries in the United States from 2017 to 2019
Murphy MJ, Cheraghlou S, Damsky W, Cohen JM. Utilization, cost, and prescription patterns of dupilumab among Medicare beneficiaries in the United States from 2017 to 2019. Journal Of Dermatological Treatment 2022, 33: 3214-3215. PMID: 36137225, DOI: 10.1080/09546634.2022.2127304.Peer-Reviewed Original ResearchTrends in the Cost and Utilization of Omalizumab in the Medicare Population: 2013-2017.
Cheraghlou S, Ugwu N, Yu B, Cohen JM. Trends in the Cost and Utilization of Omalizumab in the Medicare Population: 2013-2017. The Yale Journal Of Biology And Medicine 2022, 95: 207-212. PMID: 35782473, PMCID: PMC9235260.Peer-Reviewed Original Research
2021
Utilization and cost of bexarotene in the Medicare population: 2013 to 2017
King ALO, Lee V, Ugwu N, Cohen JM. Utilization and cost of bexarotene in the Medicare population: 2013 to 2017. Journal Of Dermatological Treatment 2021, 33: 2400-2401. PMID: 34374604, DOI: 10.1080/09546634.2021.1967264.Peer-Reviewed Original ResearchCost-effectiveness of skin biopsies performed by non-physician clinicians for Medicare beneficiaries.
Gronbeck C, Feng PW, Cohen JM, Feng H. Cost-effectiveness of skin biopsies performed by non-physician clinicians for Medicare beneficiaries. Dermatology Online Journal 2021, 27 PMID: 34387052, DOI: 10.5070/d327654051.Peer-Reviewed Original ResearchMeSH KeywordsBiopsyCost-Benefit AnalysisDermatologyHumansMedicarePhysician AssistantsSkinUnited StatesPhotodynamic Therapy and Medicare Expenditures—Reply
Cheraghlou S, Feng H, Cohen JM. Photodynamic Therapy and Medicare Expenditures—Reply. JAMA Dermatology 2021, 157: 357-357. PMID: 33502430, DOI: 10.1001/jamadermatol.2020.4657.Peer-Reviewed Original Research
2020
Early Adoption of Dupilumab in the Medicare Population in 2017.
Cheraghlou S, Cohen JM. Early Adoption of Dupilumab in the Medicare Population in 2017. The Yale Journal Of Biology And Medicine 2020, 93: 675-677. PMID: 33380928, PMCID: PMC7757055.Peer-Reviewed Original ResearchConceptsAtopic dermatitisRural-Urban Continuum CodesMedicare populationHealth Statistics Urban-Rural Classification SchemeInjectable biologicsSevere atopic dermatitisRetrospective cohort studyCohort studyPatient outcomesDupilumabFirst drugMedicare Provider UtilizationFDA approvalUtilization trendsFirst FDAFuture interventionsProvider UtilizationPotential targetBiologicsDisease treatmentPatientsTreatmentFirst yearMore rural regionsContinuum CodesUtilization and cost of topical calcineurin inhibitors in the Medicare population: 2013 to 2017
Ugwu N, Cheraghlou S, Cohen JM. Utilization and cost of topical calcineurin inhibitors in the Medicare population: 2013 to 2017. Journal Of The American Academy Of Dermatology 2020, 85: 1345-1346. PMID: 33137441, DOI: 10.1016/j.jaad.2020.10.074.Peer-Reviewed Original ResearchTrends in the Access and Cost of Photodynamic Therapy Among Medicare Beneficiaries in the United States, 2012-2017
Cheraghlou S, Feng H, Cohen JM. Trends in the Access and Cost of Photodynamic Therapy Among Medicare Beneficiaries in the United States, 2012-2017. JAMA Dermatology 2020, 156: 1021-1022. PMID: 32697282, PMCID: PMC7376476, DOI: 10.1001/jamadermatol.2020.2427.Peer-Reviewed Original ResearchUtilization, cost, and provider trends in patch testing among Medicare beneficiaries in the United States from 2012 to 2017
Cheraghlou S, Watsky KL, Cohen JM. Utilization, cost, and provider trends in patch testing among Medicare beneficiaries in the United States from 2012 to 2017. Journal Of The American Academy Of Dermatology 2020, 85: 1218-1226. PMID: 32387633, DOI: 10.1016/j.jaad.2020.04.163.Peer-Reviewed Original Research
2019
Antibiotic prescribing trends among US dermatologists in Medicare from 2013 to 2016
Kakpovbia E, Feng H, Feng PW, Cohen JM. Antibiotic prescribing trends among US dermatologists in Medicare from 2013 to 2016. Journal Of Dermatological Treatment 2019, 32: 70-72. PMID: 31122085, DOI: 10.1080/09546634.2019.1623372.Peer-Reviewed Original ResearchConceptsOral antibiotic prescriptionsOral antibioticsAntibiotic prescriptionsImportant public health issueAntibiotic prescription practicesAntibiotic prescribing trendsMedicare Part D Prescriber Public Use FilePart D Prescriber Public Use FileProportion of prescriptionsPublic health issuePrescribing trendsRetrospective reviewPrescription practicesOptimal careInflammatory diseasesMedicare patientsMedicare claimsElderly populationNumber of dermatologistsPublic Use FileUS dermatologistsDermatologistsHealth issuesMost antibioticsAdverse effects
2018
Access to injectable biologic medications by medicare beneficiaries: geographic distribution of US dermatologist prescribers
Feng H, Cohen JM, Neimann AL. Access to injectable biologic medications by medicare beneficiaries: geographic distribution of US dermatologist prescribers. Journal Of Dermatological Treatment 2018, 30: 237-239. PMID: 30078341, DOI: 10.1080/09546634.2018.1508819.Peer-Reviewed Original Research